Ohio Public Employees Retirement System (OPERS)’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-27,150
Closed -$421K – 2357
2026
Q1
$421K Hold
27,150
– – ﹤0.01% 1523
2025
Q4
$515K Buy
+27,150
New +$390K ﹤0.01% 1500
2024
Q3
– Sell
-22,138
Closed -$462K – 2322
2024
Q2
$462K Sell
22,138
-28,700
-56% -$447K ﹤0.01% 1285
2024
Q1
$747K Buy
50,838
+1,820
+4% +$19.6K ﹤0.01% 1179
2023
Q4
$506K Buy
49,018
+12,880
+36% +$88.3K ﹤0.01% 1264
2023
Q3
$284K Sell
36,138
-49,848
-58% -$455K ﹤0.01% 1318
2023
Q2
$859K Sell
85,986
-5,493
-6% -$56K ﹤0.01% 1185
2023
Q1
$812K Buy
91,479
+7,764
+9% +$80.9K ﹤0.01% 1195
2022
Q4
$919K Buy
83,715
+8,976
+12% +$108K ﹤0.01% 1185
2022
Q3
$974K Buy
74,739
+16,087
+27% +$255K ﹤0.01% 1219
2022
Q2
$743K Buy
58,652
+15,697
+37% +$178K ﹤0.01% 1296
2022
Q1
$602K Buy
42,955
+14,164
+49% +$251K ﹤0.01% 1320
2021
Q4
$833K Hold
28,791
– – ﹤0.01% 1277
2021
Q3
$863K Hold
28,791
– – ﹤0.01% 1271
2021
Q2
$764K Hold
28,791
– – ﹤0.01% 1289
2021
Q1
$895K Buy
+28,791
New +$1.09M ﹤0.01% 1245

Other funds holding NRIX

Ohio Public Employees Retirement System (OPERS)'s NRIX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Nurix Therapeutics (NRIX) in Q2 2026, closing a stake of 27,150 shares — an estimated $421K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in NRIX in Q1 2021 and held it in 16 quarters. The position peaked at $974K in Q3 2022. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Nurix Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 27,150 Nurix Therapeutics shares in Q2 2026, an estimated $421K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Nurix Therapeutics in Q1 2021 and held it in 16 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Nurix Therapeutics position peaked at $974K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.